Analysis of serum lipid profiles, metal ions and thyroid hormones levels abnormalities in β-thalassaemic children of Bangladesh

Journal of the Pakistan Medical Association

Volumn 60, Issue 5, 2010, Pages 360-364

  Ferdaus, Mohammed Zubaerul ^a   Mahbub Hasan, A K M ^b   Shekhar, Hossain Uddin ^b  

^a Novartis (Bangladesh) Limited   (Bangladesh)

^b UNIVERSITY OF DHAKA   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COPPER; DEFEROXAMINE; FERRITIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; METAL ION; THYROID HORMONE; THYROTROPIN; ZINC; LIPID; METAL;

ARTICLE; BANGLADESH; BETA THALASSEMIA; CHILD; CHOLESTEROL BLOOD LEVEL; COPPER BLOOD LEVEL; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; IRON CHELATION; LIOTHYRONINE BLOOD LEVEL; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROGNOSIS; SCHOOL CHILD; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; ZINC BLOOD LEVEL; ADOLESCENT; AGE; BLOOD; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; AGE FACTORS; BANGLADESH; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; FEMALE; HUMANS; LIPIDS; MALE; METALS; SEX FACTORS; THYROID HORMONES;

EID: 77951217992     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Koren A, Gartv I, Antonelli D, Katzuni E. Right ventricular cardiac dysfunction in b thalassaemia major. Am J Dis Child 1987; 141: 93-6.
2. Zurlo MG, Stefano P, Borgna-Pignatti C, Di-Palma A, Piga A, Melevendi C, et al. Survival and cases of death in thalassaemia major. Lancet 1989; 2: 27-30.
3. Kremastinos D, Tiniakos G, Thedorakis GN, Katritsis DG, Pavlos K. Myocarditis in thalassaemia major. A cause of heart failure. Circulation 1995; 91: 66-71.
4. The Criteria Committee of the New York Heart Association. Disease of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis. 6th ed. Boston: Little, Brown and Company 1964; pp 114.
5. Gotto AM Jr. Lipid and lipoprotein disorders. In: Pearson TA, Criqui MH, eds. Primer in Preventive Cardiology. Dallas, Texas: American Heart Association 1994; pp 107-29.
6. Ginsberg HN. Lipoprotein metabolism and its relationship to atherosclerosis. Med Clin North Am 1994; 78: 1-20.
7. Wilson PWF, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. Arteriosclerosis 1988; 8: 737-41.
8. Executive summary of the third report of the National Cholesterol Educational Program Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 2001; 285: 2486-97.
9. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Eur Heart J 2001; 22: 1527-60.
10. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skocumas J, Stefanadis C. Status and management of blood lipids in Greek adults and their relation to socio-demographic, lifestyle and dietary factors: the ATTICA Study. Atherosclerosis 2004; 173: 353-61.
11. Brewer Jr HB. New features of the National Cholesterol Education Program Adult Treatment Panel III lipid-lowering guidelines. Clin Cardiol 2003; 26: 19-24.
12. Bersot TP, Pepin GM, Mahley RW. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol. Am Heart J 2003; 146: 1052-9.
13. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PW, et al. Lipoprotein (a) levels and risk for coronary heart disease in men aged 55 years old and younger; a prospective study. JAMA 1996; 276: 544-8.
14. Dionyssiou-Asteriou A, Rizos I. Serum lipoprotein-(a) levels in a Greek population sample without a history of premature myocardial infarction. J Cardiovasc Risk 1996; 3: 277-80.
15. Papanastasiou DA, Siorokou T, Haliotis FA. Beta-Thalassaemia and factors affecting the metabolism of lipids and lipoproteins. Haematologia (Budap). 1996; 27: 143-53.
16. Maioli M, Vigna GB, Tonolo G, Brizzi P, Ciccarese M, Donega P, et al. Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in beta-thalassaemia. Atherosclerosis 1997; 131: 127-33.
17. Maioli M, Cuccuru GB, Pranzetti P, Pacifico A, Cherchi GM. Plasma lipids and lipoproteins pattern in beta-thalassaemia major. Acta Haematol 1984; 71: 106-10.
18. Maioli M, Pettinato S, Cherchi GM, Giraudi D, Pacifico A, Pupita G, et al. Plasma lipids in beta-thalassaemia minor. Atherosclerosis 1989; 75: 245-8.
19. Giardini O, Murgia F, Martino F, Mannarino O, Corrado G, Maggiani G. Serum lipid pattern in beta-thalassaemia. Acta Haematol 1978; 60: 100-7.
20. Hartman C, Tamary H, Tamir A, Shabad E, Levine C, Koren A, et al. Hypocholesterolemia in children and adolescents with beta-thalassaemia intermedia. J Pediatr 2002; 141: 543-7.
21. Theodoridis C, Ladis V, Papatheodorous A, Berdousi H, Palamidou F, Evagelopoulou C, et al. Growth and management of short stature in thalassaemia major. J Pediatr Endocrinol Metab 1998; Suppl 3: 835-44.
22. Arcasoy A, Cavdar AO, Ertug H, eds. Zinc deficiency in human subject. New York: Alan R Liss Inc 1983; pp 107-16.
23. Kwan EY, Lee AC, Li AM, Tam SC, Chan CF, Lou YL, et al. A cross-sectional study of groeth, puberty and endocrine fuction in patients with thalassaemia major in Hong Kong. J Paediatr Child Health 1995; 31: 83-7.
24. Mahmoodi MR, Kimiagar SM. Prevalence of zinc deficiency in junior high school students of Tehran City. Biol Trace Elem Res 2001; 81: 93-103.
25. Vullo C, De Sanctis V, Katz M, Wonke B, Hoffbrand AV, Bagni B, et al. Endocrine abnormalities in thalassaemia. Ann NY Acad Sci 1990; 612: 293-310.